BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 14769377)

  • 1. NO inhibition of the magnocellular neuroendocrine system in rats is independent of cGMP signaling pathway.
    Terrell ML; Salas N; Bui V; Summy-Long JY; Kadekaro M
    Exp Neurol; 2003 Dec; 184(2):846-56. PubMed ID: 14769377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of nitric oxide synthase and nitric oxide-sensitive guanylate cyclase in the crustacean cardiac ganglion.
    Scholz NL; Labenia JS; de Vente J; Graubard K; Goy MF
    J Comp Neurol; 2002 Dec; 454(2):158-67. PubMed ID: 12412140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different roles of two nitric oxide activated pathways in spinal long-term potentiation of C-fiber-evoked field potentials.
    Zhang XC; Zhang YQ; Zhao ZQ
    Neuropharmacology; 2006 May; 50(6):748-54. PubMed ID: 16427664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central nitric oxide blocks vasopressin, oxytocin and atrial natriuretic peptide release and antidiuretic and natriuretic responses induced by central angiotensin II in conscious rats.
    Reis WL; Giusti-Paiva A; Ventura RR; Margatho LO; Gomes DA; Elias LL; Antunes-Rodrigues J
    Exp Physiol; 2007 Sep; 92(5):903-11. PubMed ID: 17513344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide modulation of the hypothalamo-neurohypophyseal system.
    Kadekaro M
    Braz J Med Biol Res; 2004 Apr; 37(4):441-50. PubMed ID: 15064807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of interleukin-1beta in the magnocellular system to salt-loading.
    Summy-Long JY; Hu S; Pruss A; Chen X; Phillips TM
    J Neuroendocrinol; 2006 Dec; 18(12):926-37. PubMed ID: 17076768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burn-induced lung damage in rat is mediated by a nitric oxide/cGMP system.
    Chen LW; Hwang YC; Chen CJ; Wang JS; Chen JS; Hsu CM
    Shock; 2003 Oct; 20(4):369-74. PubMed ID: 14501952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats.
    Ciosek J; Cisowska A
    J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in the central vasopressin and oxytocin axis after lesion of a brain osmotic sensory region.
    Oliveira GR; Franci CR; Rodovalho GV; Franci JA; Morris M; Rocha MJ
    Brain Res Bull; 2004 Jul; 63(6):515-20. PubMed ID: 15249117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ghrelin induces growth hormone secretion via a nitric oxide/cGMP signalling pathway.
    Rodríguez-Pacheco F; Luque RM; Tena-Sempere M; Malagón MM; Castaño JP
    J Neuroendocrinol; 2008 Mar; 20(3):406-12. PubMed ID: 18208548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of central NO-cGMP pathway in vasopressin and oxytocin gene expression during sepsis.
    Oliveira-Pelegrin GR; Aguila FA; Basso PJ; Rocha MJ
    Peptides; 2010 Oct; 31(10):1847-52. PubMed ID: 20621145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of intracerebroventricular application of 8-Br-cGMP and LY-83,583, a guanylyl cyclase inhibitor, on sleep-wake activity in rats.
    Ribeiro AC; Kapás L
    Brain Res; 2005 Jul; 1049(1):25-33. PubMed ID: 15922313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nitric oxide-guanosine 3',5'-cyclic monophosphate pathway regulates dopamine efflux in the medial preoptic area and copulation in male rats.
    Sato SM; Hull EM
    Neuroscience; 2006 May; 139(2):417-28. PubMed ID: 16483721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium/calmodulin-dependent nitric oxide synthase activity in the CNS of Aplysia californica: biochemical characterization and link to cGMP pathways.
    Bodnárová M; Martásek P; Moroz LL
    J Inorg Biochem; 2005 Apr; 99(4):922-8. PubMed ID: 15811509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve-induced release of nitric oxide from the rabbit corpus cavernosum is modulated by cyclic guanosine 3',5'-monophosphate.
    Hallén K; Gustafsson LE; Wiklund NP
    Neuroscience; 2005; 133(1):169-74. PubMed ID: 15893640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the cGMP signaling pathway by melatonin in pancreatic beta-cells.
    Stumpf I; Bazwinsky I; Peschke E
    J Pineal Res; 2009 Mar; 46(2):140-7. PubMed ID: 19175857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver.
    Guarino MP; Correia NC; Lautt WW; Macedo MP
    Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G527-32. PubMed ID: 15331351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential contribution of nitric oxide and cGMP to the stimulatory effects of growth hormone-releasing hormone and low-concentration somatostatin on growth hormone release from somatotrophs.
    Luque RM; Rodríguez-Pacheco F; Tena-Sempere M; Gracia-Navarro F; Malagón MM; Castaño JP
    J Neuroendocrinol; 2005 Sep; 17(9):577-82. PubMed ID: 16101896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid modulation of neuronal activity and hormone secretion induced by blood volume expansion.
    Ruginsk SG; Oliveira FR; Margatho LO; Vivas L; Elias LL; Antunes-Rodrigues J
    Exp Neurol; 2007 Aug; 206(2):192-200. PubMed ID: 17553493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal interstitial guanosine cyclic 3', 5'-monophosphate mediates pressure-natriuresis via protein kinase G.
    Jin XH; McGrath HE; Gildea JJ; Siragy HM; Felder RA; Carey RM
    Hypertension; 2004 May; 43(5):1133-9. PubMed ID: 15007031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.